The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
This study aimed to identify the prognostic factors in patients with Waldeyer's ring diffuse large B‐cell lymphoma (WR‐DLBCL), comparing the efficacy of radiotherapy (RT) for the WR‐DLBCL patients in the pre‐rituximab and rituximab eras. We conducted a retrospective analysis of 134 patients diagnosed with WR‐DLBCL. Univariate and multivariate analyses were performed to identify the prognostic factors...
De novo CD5‐positive diffuse large B‐cell lymphoma (CD5+ DLBCL) is increasingly recognized as a distinct pathologic phenomenon with a specific clinical picture. However, CD5+ DLBCL has not been studied on a large scale in China. In this study, we show that CD5+ DLBCL occurs at a low frequency (9.2%). Comparison of clinical characteristics of CD5+ vs CD5− DLBCL showed that CD5+ DLBCL was more frequently...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.